To confirm the interaction between CD2BP2‐DT and YBX1 in breast cancer cells, we conducted biotin‐labeled RNA pull‐down and RNA immunoprecipitation (RIP) assays (Figure 3E,F). Here, YBX1 is linked to breast cancer.